Sanofi-Aventis expanding diabetes range in India
This article was originally published in Scrip
Executive Summary
Sanofi-Aventis is planning to expand its range of product offerings in the diabetes segment in India, which has long been considered the diabetes capital of the world, although it was recently surpassed by China.